Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.
Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.
复制标题
DOI:
10.1007/s11060-010-0376-5
复制
发表时间:
2011-06
影响因子:
3.9
通讯作者:
Vicente MG
中科院分区:
文献类型:
--
作者:
Kawabata S;Yang W;Barth RF;Wu G;Huo T;Binns PJ;Riley KJ;Ongayi O;Gottumukkala V;Vicente MG
Boron neutron capture therapy (BNCT) is based on the nuclear capture and fission reactions that occur when non-radioactive 10B is irradiated with low energy thermal neutrons to produce α-particles (10B[n,α]7Li). Carboranylporphyrins are a class of substituted porphyrins containing multiple carborane clusters. Three of these have been evaluated in the present study: 5,10,15,20-tetra-(4-nido-carboranyphenyl)tetrabenzoporphyrin (H2TBP), 5,10,15,20-tetra-(4-nido-carboranylphenyl)porphyrin (H2TCP) and 5,15-di-[3,5-(nido-carboranylmethyl)phenyl]-porphyrin (H2DCP). The goals of this study were two-fold. First, to determine the biodistribution of H2TBP, H2TCP and H2DCP following intracerebral (i.c.) administration by means of short term (30 min) convection enhanced delivery (CED) or sustained delivery over 24 h by osmotic pumps to F98 glioma bearing rats. Second, to determine the efficacy of H2TCP and H2TBP as boron delivery agents for BNCT in F98 glioma bearing rats. Tumor boron concentrations immediately after i.c. osmotic pump delivery were high (36–88 µg/g) and they remained so at 24 h (62–103 µg/g) The corresponding normal brain concentrations were low (0.8–5.2 µg/g) and the blood and liver concentrations were all undetectable. Based on these data, therapy studies were initiated at the Massachusetts Institute of Technology (MIT) Research Reactor (MITRR) with H2TCP and H2TBP 24 h after CED or osmotic pump delivery. Mean survival times (MST) of untreated and irradiated control rats were 23±3 and 27±3 d, respectively, while animals that received H2TCP or H2TBP, followed by BNCT, had a MST of 35±4 d and 44±10 d, respectively, which were better than those obtained following i.v. administration of boronophenylalanine (37±3 d). However, since the tumor boron concentrations of the carboranylporphyrins were 3–5X > i.v. BPA (~25 µg/g), we had expected that the MSTs would have been greater. Histopathologic examination of brains of BNCT treated rats revealed that there were large numbers of porphyrin-laden macrophages, as well as extracellular accumulations of porphyrins indicating that the seemingly high tumor boron concentrations did not represent the true tumor cellular uptake. Our data are the first to show that carboranyl porphyrins are effective delivery agents for BNCT of an experimental brain tumor. Based on these results, we now are in the process of evaluating carboranylporphyrins that could have enhanced cellular uptake following administration and improved therapeutic efficacy.
登录
查看更多内容
影响因子:
4.1
作者:
CEBERG, CP;BRUN, A;SALFORD, LG
通讯作者:
SALFORD, LG
DOI:
10.1016/j.jphotobiol.2007.09.012
发表时间:
2007-12-14
影响因子:
5.4
作者:
Fabris, Clara;Vicente, M. Graca H.;Soncin, Marina
通讯作者:
Soncin, Marina
DOI:
10.1016/s0360-3016(00)00421-1
发表时间:
2000-04-01
影响因子:
7
作者:
Barth, RF;Yang, WL;Goodman, JH
通讯作者:
Goodman, JH
影响因子:
1.5
作者:
Bobadova-Parvanova, P;Oku, Y;Vicente, MGH
通讯作者:
Vicente, MGH
影响因子:
3.5
作者:
Gottumukkala, V;Ongayi, O;Vicente, MGH
通讯作者:
Vicente, MGH